{"id":17014,"date":"2024-12-06T17:49:50","date_gmt":"2024-12-06T09:49:50","guid":{"rendered":"https:\/\/flcube.com\/?p=17014"},"modified":"2025-03-03T15:29:53","modified_gmt":"2025-03-03T07:29:53","slug":"gsk-plc-partners-with-muna-therapeutics-to-discover-alzheimers-disease-treatment-targets","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=17014","title":{"rendered":"GSK plc Partners with Muna Therapeutics to Discover Alzheimer\u2019s Disease Treatment Targets"},"content":{"rendered":"\n

GSK plc (NYSE: GSK<\/a>) has announced a new partnership with Danish biotech firm Muna Therapeutics, following recent collaborations with Sino-US Duality Biologics and US biotech Rgenta Therapeutics. This latest alliance aims to identify and validate novel drug targets for the treatment of Alzheimer\u2019s disease, leveraging insights from Muna\u2019s MiND-MAP platform, which utilizes spatial transcriptomics on brain samples from Alzheimer\u2019s patients and cognitively resilient individuals.<\/p>\n\n\n\n

MiND-MAP Platform and Its Role in Alzheimer\u2019s Research<\/strong>
Muna\u2019s MiND-MAP platform applies advanced spatial transcriptomics to analyze brain samples, providing valuable insights into the pathology of Alzheimer\u2019s disease. This technology enables a deeper understanding of the disease\u2019s impact and may uncover new therapeutic targets for drug development.<\/p>\n\n\n\n

Financial Terms and Collaboration Structure<\/strong>
Under the agreement, Muna will receive an upfront payment of EUR 33.5 million and is eligible to receive up to EUR 140 million in milestone payments per target, as well as tiered royalties on net sales of products that result from the collaboration. Muna will expand its MiND-MAP dataset and lead the identification and validation of new Alzheimer\u2019s disease targets.<\/p>\n\n\n\n

GSK\u2019s Commitment to Drug Development<\/strong>
GSK will take the lead in drug development, managing preclinical activities, clinical development, manufacturing, and commercialization of any products discovered and validated through the collaboration. This strategic partnership combines Muna\u2019s expertise in target identification with GSK\u2019s drug development capabilities, aiming to accelerate the discovery of new treatments for Alzheimer\u2019s disease.-Fineline Info & Tech<\/a><\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

GSK plc (NYSE: GSK) has announced a new partnership with Danish biotech firm Muna Therapeutics,…<\/p>\n","protected":false},"author":1,"featured_media":17016,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[232,3795,184,2639,914,2630],"class_list":["post-17014","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-duality-biologics","tag-duality-biotherapeutics","tag-gsk","tag-muna-therapeutics","tag-nyse-gsk","tag-rgenta-therapeutics"],"yoast_head":"\nGSK plc Partners with Muna Therapeutics to Discover Alzheimer\u2019s Disease Treatment Targets - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"GSK plc (NYSE: GSK) has announced a new partnership with Danish biotech firm Muna Therapeutics, following recent collaborations with Sino-US Duality Biologics and US biotech Rgenta Therapeutics. This latest alliance aims to identify and validate novel drug targets for the treatment of Alzheimer\u2019s disease, leveraging insights from Muna\u2019s MiND-MAP platform, which utilizes spatial transcriptomics on brain samples from Alzheimer\u2019s patients and cognitively resilient individuals.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=17014\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GSK plc Partners with Muna Therapeutics to Discover Alzheimer\u2019s Disease Treatment Targets\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=17014\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-06T09:49:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-03T07:29:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/0688.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=17014#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=17014\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"GSK plc Partners with Muna Therapeutics to Discover Alzheimer\u2019s Disease Treatment Targets\",\"datePublished\":\"2024-12-06T09:49:50+00:00\",\"dateModified\":\"2025-03-03T07:29:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=17014\"},\"wordCount\":258,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=17014#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/0688.png\",\"keywords\":[\"Duality Biologics\",\"Duality Biotherapeutics\",\"GSK\",\"Muna Therapeutics\",\"NYSE: GSK\",\"Rgenta Therapeutics\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=17014#respond\"]}],\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=17014\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=17014\",\"name\":\"GSK plc Partners with Muna Therapeutics to Discover Alzheimer\u2019s Disease Treatment Targets - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=17014#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=17014#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/0688.png\",\"datePublished\":\"2024-12-06T09:49:50+00:00\",\"dateModified\":\"2025-03-03T07:29:53+00:00\",\"description\":\"GSK plc (NYSE: GSK) has announced a new partnership with Danish biotech firm Muna Therapeutics, following recent collaborations with Sino-US Duality Biologics and US biotech Rgenta Therapeutics. This latest alliance aims to identify and validate novel drug targets for the treatment of Alzheimer\u2019s disease, leveraging insights from Muna\u2019s MiND-MAP platform, which utilizes spatial transcriptomics on brain samples from Alzheimer\u2019s patients and cognitively resilient individuals.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=17014#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=17014\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=17014#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/0688.png\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/0688.png\",\"width\":1080,\"height\":560,\"caption\":\"GSK plc Partners with Muna Therapeutics to Discover Alzheimer\u2019s Disease Treatment Targets\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=17014#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GSK plc Partners with Muna Therapeutics to Discover Alzheimer\u2019s Disease Treatment Targets\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"GSK plc Partners with Muna Therapeutics to Discover Alzheimer\u2019s Disease Treatment Targets - Insight, China's Pharmaceutical Industry","description":"GSK plc (NYSE: GSK) has announced a new partnership with Danish biotech firm Muna Therapeutics, following recent collaborations with Sino-US Duality Biologics and US biotech Rgenta Therapeutics. This latest alliance aims to identify and validate novel drug targets for the treatment of Alzheimer\u2019s disease, leveraging insights from Muna\u2019s MiND-MAP platform, which utilizes spatial transcriptomics on brain samples from Alzheimer\u2019s patients and cognitively resilient individuals.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=17014","og_locale":"en_US","og_type":"article","og_title":"GSK plc Partners with Muna Therapeutics to Discover Alzheimer\u2019s Disease Treatment Targets","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=17014","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2024-12-06T09:49:50+00:00","article_modified_time":"2025-03-03T07:29:53+00:00","og_image":[{"width":1080,"height":560,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/0688.png","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=17014#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=17014"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"GSK plc Partners with Muna Therapeutics to Discover Alzheimer\u2019s Disease Treatment Targets","datePublished":"2024-12-06T09:49:50+00:00","dateModified":"2025-03-03T07:29:53+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=17014"},"wordCount":258,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=17014#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/0688.png","keywords":["Duality Biologics","Duality Biotherapeutics","GSK","Muna Therapeutics","NYSE: GSK","Rgenta Therapeutics"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=17014#respond"]}],"copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=17014","url":"https:\/\/flcube.com\/?p=17014","name":"GSK plc Partners with Muna Therapeutics to Discover Alzheimer\u2019s Disease Treatment Targets - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=17014#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=17014#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/0688.png","datePublished":"2024-12-06T09:49:50+00:00","dateModified":"2025-03-03T07:29:53+00:00","description":"GSK plc (NYSE: GSK) has announced a new partnership with Danish biotech firm Muna Therapeutics, following recent collaborations with Sino-US Duality Biologics and US biotech Rgenta Therapeutics. This latest alliance aims to identify and validate novel drug targets for the treatment of Alzheimer\u2019s disease, leveraging insights from Muna\u2019s MiND-MAP platform, which utilizes spatial transcriptomics on brain samples from Alzheimer\u2019s patients and cognitively resilient individuals.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=17014#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=17014"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=17014#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/0688.png","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/0688.png","width":1080,"height":560,"caption":"GSK plc Partners with Muna Therapeutics to Discover Alzheimer\u2019s Disease Treatment Targets"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=17014#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"GSK plc Partners with Muna Therapeutics to Discover Alzheimer\u2019s Disease Treatment Targets"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/0688.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/17014","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17014"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/17014\/revisions"}],"predecessor-version":[{"id":17017,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/17014\/revisions\/17017"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/17016"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=17014"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=17014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}